Adverse events as predictive factors of therapeutic activity in patients with hcc treated with atezolizumab plus bevacizumab
Yuri Tsujimoto,Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Masashi Hirooka,Kazuya Kariyama, Ei Itobayashi, Tsuji Kunihiko, Toru Ishikawa,Hidenori Toyoda,Takeshi Hatanaka,Satoru Kakizaki,Hideko Ohama,Fujimasa Tada, Kazuhiro Nouso,Yoichi Hiasa HEPATOLOGY（2023）
AI 理解论文
溯源树
样例
